SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001214659-23-001038
Filing Date
2023-01-24
Accepted
2023-01-24 16:03:15
Documents
2
Period of Report
2023-01-20

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT marketforms-58261.html 4  
1 PRIMARY DOCUMENT marketforms-58261.xml 4 5610
2 POA DOCUMENT poa.htm EX-24 3102
  Complete submission text file 0001214659-23-001038.txt   10062
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Sharp Shalini (Reporting) CIK: 0001377202 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 23548164

Mailing Address 3545 CRAY COURT SAN DIEGO CA 92121
Business Address 3545 CRAY COURT SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

IRS No.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations